Effect of 2-mercaptoacetate and 2-deoxy-D-glucose administration on the expression of NPY, AGRP, POMC, MCH and hypocretin/orexin in the rat hypothalamus
V. Sergeyev et al., Effect of 2-mercaptoacetate and 2-deoxy-D-glucose administration on the expression of NPY, AGRP, POMC, MCH and hypocretin/orexin in the rat hypothalamus, NEUROREPORT, 11(1), 2000, pp. 117-121
Using in situ hybridization, the mRNA levels encoding neuropeptide Y (NPY),
agouti gene-related protein (AGRP), proopiomelanocortin (POMC), melanin-co
ncentrating hormone (MCH) and hypocretin/orexin (HC/ORX) were investigated
in the rat arcuate nucleus (Arc) and lateral hypothalamic area (LHA) 2 h af
ter a single dose of the glucose antimetabolite 2-deoxy-D-glucose (2-DG; 60
0 mg/kg) or of the fatty acid oxidation inhibitor mercaptoacetate (MA; 600
mu mol/kg). Two hours after 2-DG or MA injection food intake was significan
tly increased. NPY and AGRP mRNA levels in the Are were increased by 2-DG b
ut not affected by MA, and MCH mRNA levels in the LHA were increased by bot
h antimetabolites. These results suggest that Are neurons expressing NPY an
d AGRP are regulated by changes in glucose, but not fatty acid availability
, whereas both factors affect MCH neurons in the LHA. NeuroReport 11:117-12
1 (C) 2000 Lippincott Williams & Wilkins.